Interv Akut Kardiol. 2003;2(2):61-68

Our experiences with endovascular treatment of ileofemoral venous thrombosis

Miroslav Chochola1, Petr Vařejka1, Simon Jirát1, Michael Aschermann1, Jiří Křivánek2, Karel Goričan3, Radka Klézlová4
1 II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha
2 Radiodiagnostická klinika 1. LF UK, oddělení magnetické rezonance, Praha
3 IV. interní klinika VFN a 1. LF UK, Praha
4 Interní oddělení ÚVN, Praha

Objective: Goal of our treatment was an evaluation of primary and long-term efficacy of endovascular treatment in patients with ileofemoral venous thrombosis.

Data and methods: We have treated 44 extremities in 38 patients with diagnosis of ileofemoral venous thrombosis with local continuous thrombolysis. Right lower extremity has been treated 8 times (18,2 %) and left lower extremity 36 (81.2 %) times. There were 9 men (24 %) and 29 women (76 %) in the group. Average age was 28,7 years (range 17–66). Average duration of thrombosis was 9,7 (1–21) days. For the treatment of thrombosis rt-PA was used in 40 (88,8 %) extremities and urokinase in 5 (11,2 %) extremities. Average total dose of urokinase was 7.7 (6 – 16.5) million units and average time of thrombolysis duration was 78 (60–110) hours. Average total dose when using rt-PA was 44,86 (20–80) mg and average duration of thrombolysis was 46 (12–72) hours. Among adjuvant techniques, percutaneous transluminal angioplasty was used in the treatment of 30 (68,2 %) extremities, percutaneous mechanical thrombectomy was used in 11 (25 %) extremities. We have implanted 24 stents in 20 (45,4 %) extremities. We have used temporary caval filter in 16 (42,1 %) patients.

Results: Primary success was achieved in the treatment of 37 (84,1 %) extremities. Three month later was 35 (79,5 %) extremities without signs of re-thrombosis in the treated area, six months later 33 (75 %) extremities, twelve months later 31 (70,4 %) extremities, twenty four months later 28 (63,6 %) extremities. All patients with a stent have had treated area clear in 100 % after 12 months. Closure of 1 stent occurred after 24 months. We have experienced 6 (15,7 %) minor and 4 (10,5 %) serous complications during the treatment. Diagnosis of post-thrombotic syndrome or chronic venous insufficiency was stated in 18 (40,9 %) extremities. No patient has undergone pulmonary embolisation nor died.

Conclusion: Results of study present local continuous thrombolysis with combination of percutaneous transluminal angioplasty and stenting as efficient method resulting in passage return of deep venous system and in elimination of acute symptoms in majority of patients with diagnosis of ileofemoral venous thrombosis under condition keeping indication and contraindication criteria.

Keywords: venous thrombosis, local continuous thrombolysis, percutaneous transluminal angioplasty, stent.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chochola M, Vařejka P, Jirát S, Aschermann M, Křivánek J, Goričan K, Klézlová R. Our experiences with endovascular treatment of ileofemoral venous thrombosis. Interv Akut Kardiol. 2003;2(2):61-68.
Download citation

References

  1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology). American Heart Association Circulation 1996; 93: 2212-2245. Go to original source... Go to PubMed...
  2. Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of National Multicenter Registry. Radiology 1999; 211: 39-49. Go to original source... Go to PubMed...
  3. Comerota AJ. Venous thromboembolism. In Rutherford RB: Vascular Surgery. 4th ed. Philadelphia WB Saunders 1995; 1785-1790.
  4. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomised trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 1979; 66: 838-843. Go to original source... Go to PubMed...
  5. van Breda A, Graor RA, Katzen BT, et al. Relative cost-effectiveness of urokinase versus streptokinase in the treatment of peripheral vascular disease. J Vasc Intervent Radiol 1991; 2: 77-87. Go to original source... Go to PubMed...
  6. Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low-dose streptokinase. Radiology 1974; 111: 31-37. Go to original source... Go to PubMed...
  7. Rutherford R, Padberg F, Comerota AJ, et al. Venous severity scoring: an adjunct to venous outcome measurement. J Vasc Surg 2000; 1307-1312. Go to original source... Go to PubMed...
  8. Cockett FB, Thomas ML. The iliac vein compression syndrome. Br J Surg 1965; 52: 816-821. Go to original source... Go to PubMed...
  9. Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28: 826-832. Go to original source... Go to PubMed...
  10. Johnson BF, Manzo RA, Bergelin RO, et al.: Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg 1995; 21: 307-312. Go to original source... Go to PubMed...
  11. Krupski WC, Bass A, Dilley RB, et al. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg 1990; 12: 467-474. Go to original source...
  12. Bjarnason H, Kruse JR, Asinger DA, et al. Iiofemoral deep venous thrombosis: safety and efficacy outocome during 5 years of catheter-directed thrombolytic therapy. J Vasc Intervent Radiol 1997; 8: 405-418. Go to original source... Go to PubMed...
  13. Comerota AJ, Aldridge SC, Cohen G et al. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994;20:244-254. Go to original source... Go to PubMed...
  14. Hansen ME, Miler GL III, Starks KC. Pulse-spray thrombolysis of inferior vena cava thrombosis complicating filter placemet. Cardiovasc Intervent Radiol 1994; 17; 38-40. Go to original source... Go to PubMed...
  15. Hood DB, Weaver FA, Modrall JG, Yellin AE. Advances in the treatment of phlegmasia cerulea dolens. Am J Surg 1993; 166: 206-210. Go to original source... Go to PubMed...
  16. Jaffe JW, Newcomb JA, York T, Matulewitz TJ. Venous valvular assessment after retrograde catheterization. J Vasc Interv Radiol 1996; 7: 595-597. Go to original source... Go to PubMed...
  17. Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Intervent Radiol 1991; 2: 195-197. Go to original source... Go to PubMed...
  18. Palombo D, Porta C, Brustia P, et al. Loco-regional thrombolysis in deep venous thrombosis (in French). Phlebologie 1993; 46: 293-302. Go to PubMed...
  19. Robinson DL, Teitelbaum GP. Phlegmasia cerulea dolens: treatment by pulse- spray and infusion thrombolysis. Am J Roentgenol 1993; 160: 1288-1290. Go to original source... Go to PubMed...
  20. Ryu RK, Durham JD, Kumpe DA: Transcatheter venous thrombolysis-pitfalls and pratfalls: a case discussion of indications, technique, and alternatives. J Vasc Interv Radiol 1997; 8: 1005-1010. Go to original source... Go to PubMed...
  21. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: agressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494. Go to original source... Go to PubMed...
  22. Tarry WC, Makhoul RG, Tisnado J, et al. Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis. Ann Vasc Surg 1994; 8: 583-590. Go to original source... Go to PubMed...
  23. Verhaeghe R, Stockx L, Lacroix H, et al. Catheter-directed lysis of ileofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997; 7: 996-1001. Go to original source... Go to PubMed...
  24. Emanuelli G, Segramora V, Frigerio C. Selected strategies in venous thromboembolism: local thrombolytic treatment and caval filters. Haematologica 1995; Mar-Apr.80 (2 Suppl): 84-86. Go to PubMed...
  25. Molina JE, Hunter DW, Yedlicka JW. Thrombolytic therapy for ileofemoral venous thrombosis. Vasc Surg 1992; 26: 630-637. Go to original source...
  26. Raju S, Fountain T, McPherson SH: Catheter-directed thrombolysis for deep vein thrombosis. J Miss State Med Assoc 1998; 39: 81-84. Go to PubMed...
  27. Dake MD, Semba CP. Thrombolytic therapy in venous occlusive disease. J Vasc Interv Radiol 1995; 6: 73-77. Go to original source... Go to PubMed...
  28. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. Prevention du Risque d´Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338: 409-415. Go to original source... Go to PubMed...
  29. Ouriel K, Shortell CK, Azodo MV, et al. Acute peripheral arterial occlusion: predictoss of succes in catheter-directed thrombolytic therapy. Radiology 1994; 193: 561-566. Go to original source... Go to PubMed...
  30. Siragusa S, Cosmi B, Piovella F, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996; 100: 269-277. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.